Minimally invasive graphene-based implant for treating brain disorders
The MINIGRAPH project aims to develop and validate innovative brain implants with closed-loop neuromodulation capabilities controlled by implanted electronics units and miniature arrays of graphene microelectrodes.
The project will introduce a minimally invasive, high-precision implantation procedure using a single small skull incision.
Photon-Atom Non-linearities and Deterministic Applications via arrays
The PANDA project will design an array of neutral strontium atoms with subwavelength spacing to enable lossless, deterministic photon-photon interactions.
This setup, combined with efficient single-photon handling, will enable powerful non-linear operations with several quantum information processing applications.
Emergent Awareness from Minimal Collectives
The EMERGE project will enable emergent collaborative awareness among collectives of minimal artificial beings without predefined protocols.
EMERGE’s framework will offer insight that will foster allocation of awareness to optimise achievement of desired outcomes.
Revolutionising concrete production with carbon-storing, sustainable binders
C-SINC, led by Paebbl, is pioneering the development of magnesium-based silicate binders that integrate CO2-sequestered minerals like olivine and pyroxenes as sustainable cement alternatives.
This project will enable the transformation of concrete into a carbon sink, reducing embodied emissions while enhancing structural performance.
Alternative approaches to superconducting qubit technology
The FERROMON project will advance two novel superconducting qubit designs that do not introduce undesirable magnetic fields to the system.
Three of Europe’s leading quantum startups will integrate these alternative qubit types into prototype full-stack systems to test the implications of these novel approaches on scalability and performance quality.
Analytical platform tailored for cell & gene therapy manufacturing
The PAT4CTG project aims to enable in-line continuous monitoring of key cell culture parameters during therapy manufacturing.
The consortium will develops a self-contained instrument that connects miniaturized biosensor technologies to a novel bioreactor to allow automation of the entire cell therapy manufacturing process in a closed system.
Zaz Ventures Central
Square de Meeus 35+32 6 98 100 87
Zaz Ventures West
24 Greville Street+44 20 3286 2807
Zaz Ventures South
Hansmatt 32+41 315 190 109
Zaz Ventures East
7 Temasek Boulevard+65 9779 1309
